Physician profile
Rasha Ebeid
NPI 1548205859
$1,154.28
in general payments reported to CMS, 2019-2025
15 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.60 · 2023: $279 · 2024: $482 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.69 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $241.21 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $132.82 | 2023-2025 | |
| Organon LLC | $119.97 | 2022-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $118.74 | 2022-2025 | |
| Myriad Women'S Health, INC. | $90.48 | 2023 | Myrisk |
| Shield Therapeutics INC | $86.05 | 2024-2025 | |
| Optumhealth Care Solutions, LLC | $75.46 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $66.08 | 2023-2025 | Summit Doppler, Paragard T 380a, Endosee |
| Aspira Women'S Health INC | $62.77 | 2023-2024 | Ova1 |
| Abbvie INC. | $49.03 | 2025 | |
| Hologic Sales and Service, LLC | $33.80 | 2024 | Aptima |
| Becton, Dickinson and Company | $24.73 | 2025 | Bd Max System, Bd Max Instrument |
| Minerva Surgical, INC | $21.34 | 2023 | |
| Evofem Biosciences, INC. | $17.57 | 2022 | |
| Intuitive Surgical, INC. | $14.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rasha Ebeid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.